Take Your Mission Beyond the Exam Room
The field of community oncology is always changing. In a constantly evolving landscape, we must keep our finger on the pulse so we can create meaningful change for patients. To truly drive change and take this mission beyond the exam room, we must empower everyone in our community to be a stronger advocate.
The Community Oncology Alliance’s (COA) 2025 Community Oncology Conference brings together every facet of independent community oncology with the shared goal of ensuring patients have continued access to high-quality cancer care in the communities where they live and work. Joining us will be 2,000+ leaders from across the industry, including physicians, practice administrators and leaders, pharmacists and pharmacy technicians, nurses and advanced practice providers, and industry stakeholders.
Aligning with the core mission of COA is this year’s Conference theme, Empower & Advocate: Independent Community Oncology.
Over two days of learning and networking, attendees will get to choose from industry leading plenary sessions, along with four unique tracks covering clinical, business, pharmacy, and advocacy topics uniquely targeted to the needs of independent practices.
Become an empowered advocate, gain the knowledge to succeed, and network with key decision makers from across the industry at the 2025 Community Oncology Conference on April 29 – 30 outside Orlando, Florida.
Who Should Attend?
We invite all community oncology physicians, pharmacists/pharmacy techs, nurses/advanced practice providers, practice administrators/leaders, hematology/oncology fellows, policy or patient advocates, and industry stakeholders who support us. The 2025 COA Conference has something for everyone!
Don’t Miss Out On EARLY BIRD Prices – Register TODAY!
Already decided to join us? Save 20% if you qualify and complete your registration by Monday, February 24, 2025. Visit Registration Pricing, under Attend in the menu for more information.
An Agenda for Cancer Care Thought Leaders
Independent community oncology practices across the country are providing patients with high-quality, evidence-based, and cutting-edge cancer care that is affordable and accessible. Yet, they face ongoing challenges.
How can practices stay competitive among ongoing consolidation? How and when should care teams integrate new cancer care advancements into care plans? How can community oncology practices and patients leverage their collective power to make a difference in policy discussions? Those questions and others will be tackled at the 2025 COA Conference.
Detailed information on the agenda will be available soon, so keep your eyes peeled!
ACPE Credits for Returning Oncology Pharmacists
Pharmacists who attend this year’s Conference can receive continuing education (CE) credits for certain sessions through the Accreditation Council for Pharmacy Education (ACPE). These credits can help you meet your CE requirements for the year and position you for success.
More information on specific credits and courses coming soon!
Co-Chairs
Each year, the Conference co-chairs select speakers that are on the frontlines of independent community oncology. They consider not only professional accolades but connections: Are they advocates? Do they uplift other practice professionals? Are they creating diverse coalitions to create change? For each speaker at the 2025 Community Oncology Conference, the answer is yes!
The 2025 Community Oncology Conference co-chairs are:
Johnetta Blakely, MD, MS, MMHC
Tennessee Oncology
Moshe Chasky, MD, FACP
Alliance Cancer Specialists
S. Fred Divers, MD
Genesis Cancer & Blood Institute & American Oncology Network, LLC.
Kathy Oubre, MS
Pontchartrain Cancer Center
Alti Rahman, MHA/MBA, CSSBB
American Oncology Network, LLC.
Emily Touloukian, DO
Coastal Cancer Center
Meet the 2025 COA Conference Keynote Speaker
Our powerful keynote speaker this year is Dr. David Fajgenbaum whose story is one of resilience, innovation, and a relentless drive to save lives—beginning with his own. Diagnosed with the rare and life-threatening Castleman disease while still in medical school, Dr. Fajgenbaum took matters into his own hands. He identified a repurposed drug that put him into remission, sparking his mission to match existing medications with rare diseases that lack treatments. Now in remission for a decade, he has expanded this work through Every Cure, a non-profit that uses AI to unlock the untapped potential of FDA-approved drugs to treat thousands of rare diseases….
Meet the 2025 COA Conference Keynote Speaker
Our powerful keynote speaker this year is Dr. David Fajgenbaum whose story is one of resilience, innovation, and a relentless drive to save lives—beginning with his own. Diagnosed with the rare and life-threatening Castleman disease while still in medical school, Dr. Fajgenbaum took matters into his own hands. He identified a repurposed drug that put him into remission, sparking his mission to match existing medications with rare diseases that lack treatments. Now in remission for a decade, he has expanded this work through Every Cure, a non-profit that uses AI to unlock the untapped potential of FDA-approved drugs to treat thousands of rare diseases.
Dr. Fajgenbaum’s groundbreaking work recently received over $48 million in federal funding to build a comprehensive drug-repurposing database, accelerating access to life-saving treatments for patients like Kaila Mabus, an 18-year-old Castleman survivor now in remission due to his efforts. His keynote promises to be both inspiring and actionable, offering a vision for transforming treatment through innovation and tenacity.
Get Updates on the 2025 Community Oncology Conference
Want to receive Conference updates directly in your inbox? Sign up here!